GENMAB A/S/S (OTCMKTS:GMXAY – Get Free Report) crossed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $21.66 and traded as low as $20.50. GENMAB A/S/S shares last traded at $20.76, with a volume of 1,380,277 shares.
GENMAB A/S/S Stock Up 2.2 %
The business has a 50 day simple moving average of $21.66 and a 200-day simple moving average of $24.68.
About GENMAB A/S/S
Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer primarily in Denmark. The company markets DARZALEX, a human IgG1k monoclonal antibody for the treatment of patients with multiple myeloma (MM); and Arzerra, a human IgG1k monoclonal antibody for the treatment of chronic lymphocytic leukemia (CLL).
Featured Articles
- Five stocks we like better than GENMAB A/S/S
- How to Use the MarketBeat Dividend Calculator
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- 2 Drone Stocks Surging from Increased Media Attention
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for GENMAB A/S/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENMAB A/S/S and related companies with MarketBeat.com's FREE daily email newsletter.
